138 related articles for article (PubMed ID: 34435407)
1. Use of hydrochlorothiazide in Denmark following publication of skin cancer risk findings.
Pottegård A; Bech BH; Pedersen SA; Christensen B
Pharmacoepidemiol Drug Saf; 2021 Nov; 30(11):1611-1616. PubMed ID: 34435407
[TBL] [Abstract][Full Text] [Related]
2. Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark.
Pedersen SA; Gaist D; Schmidt SAJ; Hölmich LR; Friis S; Pottegård A
J Am Acad Dermatol; 2018 Apr; 78(4):673-681.e9. PubMed ID: 29217346
[TBL] [Abstract][Full Text] [Related]
3. Hydrochlorothiazide use and risk for Merkel cell carcinoma and malignant adnexal skin tumors: A nationwide case-control study.
Pedersen SA; Johannesdottir Schmidt SA; Hölmich LR; Friis S; Pottegård A; Gaist D
J Am Acad Dermatol; 2019 Feb; 80(2):460-465.e9. PubMed ID: 29913261
[TBL] [Abstract][Full Text] [Related]
4. Comment on "Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark".
van Veelen A; Nielen JTH; van Geel R; Croes S
J Am Acad Dermatol; 2021 Dec; 85(6):e357. PubMed ID: 30771418
[No Abstract] [Full Text] [Related]
5. Reply to "Comment on 'Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark'".
Pedersen SA; Pottegård A
J Am Acad Dermatol; 2021 Dec; 85(6):e359-e360. PubMed ID: 30771416
[No Abstract] [Full Text] [Related]
6. Skin Cancer and Hydrochlorothiazide: Novel Population-Based Analyses Considering Personal Risk Factors Including Race/Ethnicity.
Birck MG; Moura CS; Machado MAA; Liu JL; Abrahamowicz M; Pilote L; Bernatsky S
Hypertension; 2023 Oct; 80(10):2218-2225. PubMed ID: 37489540
[TBL] [Abstract][Full Text] [Related]
7. Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case-control study.
Pottegård A; Pedersen SA; Schmidt SAJ; Lee CN; Hsu CK; Liao TC; Shao SC; Lai EC
Br J Cancer; 2019 Nov; 121(11):973-978. PubMed ID: 31673105
[TBL] [Abstract][Full Text] [Related]
8. Chronic Use of Hydrochlorothiazide and Risk of Skin Cancer in Caucasian Adults: A PharmLines Initiative Inception Cohort Study.
Haisma MS; Greven N; Logendran M; Bos J; van der Vegt B; Horváth B; De Vos S; De Bock GH; Hak E; Rácz E
Acta Derm Venereol; 2023 Apr; 103():adv3933. PubMed ID: 37014269
[TBL] [Abstract][Full Text] [Related]
9. The use of specific antihypertensive medication and skin cancer risk: A systematic review of the literature and meta-analysis.
Heisel AGU; Vuurboom MD; Daams JG; de Rie MA; Vogt L; van den Born BH; Olde Engberink RHG
Vascul Pharmacol; 2023 Jun; 150():107173. PubMed ID: 37084802
[TBL] [Abstract][Full Text] [Related]
10. Hydrochlorothiazide use is strongly associated with risk of lip cancer.
Pottegård A; Hallas J; Olesen M; Svendsen MT; Habel LA; Friedman GD; Friis S
J Intern Med; 2017 Oct; 282(4):322-331. PubMed ID: 28480532
[TBL] [Abstract][Full Text] [Related]
11. Use of Hydrochlorothiazide and Risk of Melanoma and Nonmelanoma Skin Cancer.
Rouette J; Yin H; Pottegård A; Nirantharakumar K; Azoulay L
Drug Saf; 2021 Feb; 44(2):245-254. PubMed ID: 33104975
[TBL] [Abstract][Full Text] [Related]
12. [Hydrochlorothiazide and skin cancer].
Olde Engberink RHG; van der Hoeven NV; Zwinderman AH; van den Born BH
Ned Tijdschr Geneeskd; 2019 May; 163():. PubMed ID: 31120217
[TBL] [Abstract][Full Text] [Related]
13. Hydrochlorothiazide use and the risk of skin cancer in patients with hypertensive disorder: a nationwide retrospective cohort study from Korea.
Park E; Lee Y; Jue MS
Korean J Intern Med; 2020 Jul; 35(4):917-928. PubMed ID: 31842528
[TBL] [Abstract][Full Text] [Related]
14. Association between hydrochlorothiazide exposure and different incident skin, lip and oral cavity cancers: A series of population-based nested case-control studies.
Morales DR; Pacurariu A; Slattery J; Kurz X
Br J Clin Pharmacol; 2020 Jul; 86(7):1336-1345. PubMed ID: 32068906
[TBL] [Abstract][Full Text] [Related]
15. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
16. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
Baandrup L
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
[TBL] [Abstract][Full Text] [Related]
17. Hydrochlorothiazide treatment and risk of non-melanoma skin cancer: Review of the literature.
Garrido PM; Borges-Costa J
Rev Port Cardiol (Engl Ed); 2020 Mar; 39(3):163-170. PubMed ID: 32354458
[TBL] [Abstract][Full Text] [Related]
18. In Brief: Hydrochlorothiazide and skin cancer.
Med Lett Drugs Ther; 2020 Nov; 62(1611):177. PubMed ID: 33429413
[No Abstract] [Full Text] [Related]
19. Hydrochlorothiazide and the risk of skin cancer. A scientific statement of the British and Irish Hypertension Society.
Faconti L; Ferro A; Webb AJ; Cruickshank JK; Chowienczyk PJ;
J Hum Hypertens; 2019 Apr; 33(4):257-258. PubMed ID: 30842544
[No Abstract] [Full Text] [Related]
20. Hydrochlorothiazide use and risk of non-melanoma skin cancer in Spain: A case/non-case study.
Lecaros-Astorga DA; Molina-Guarneros JA; Rodríguez-Jiménez P; Martin-Arias LH; Sainz-Gil M
Int J Clin Pharmacol Ther; 2021 Apr; 59(4):280-288. PubMed ID: 33355085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
